Anti-fibrotic Potential of Moringa oleifera in Hepatic Fibrosis: Molecular Mechanisms and Pharmacological Evidence
Journal of Natural Remedies · 30.05.2026 · 1141-1158
DOI: 10.18311/jnr/2026/54532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Remedies, online erschienen am 30.05.2026. Verfasst von Madhurani . und 5 weiteren Autor:innen. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aim
The current review aims to critically analyse the antifibrotic potential of Moringa oleifera and summarise the molecular effects of the phytoconstituents of this compound on the hepatic pathways in fibrosis.
Methods
The pertinent scientific literature was gathered and examined in the large electronic databases such as PubMed, Google Scholar, ScienceDirect, and Web of Science. Experimental studies that investigate the pharmacological effects of Moringa oleifera in hepatic fibrosis were chosen from peer-reviewed articles. The in vitro and in vivo research articles were all analysed with a focus on the oxidative stress markers, inflammatory mediators, signal pathways, and hepatic stellate cell activation in relation to fibrogenesis.
Results
The existing preclinical research indicates ongoing availability of studies that confirm that Moringa oleifera possesses significant anti-fibrotic, anti-oxidant and anti-inflammatory properties. Its bioactive components, flavonoids, phenolic compounds, and isothiocyanates decrease oxidative stress by reducing lipid peroxidation marker malondialdehyde and also reinstating endogenous antioxidant defence systems, superoxide dismutase, catalase and glutathione systems. M. oleifera downregulates key pro-fibrotic signalling pathways at the molecular level, including TGF-β/Smad, NF-κB, and p38-MAPK. All these effects prevent hepatic stellate cell activation and reduce α-smooth muscle actin expression and collagen deposition in the extracellular matrix. Moreover, cytokine regulation, such as TNF-α, IL-1β and IL-18, also promotes the inhibition of inflammatory reactions that cause fibrosis development.
Conclusion
All in all, recent experimental data indicate that M. oleifera functions in several complementary ways to inhibit fibrogenic pathways and hepatic tissue protection. Despite its promising preclinical results that show its therapeutic benefits, these findings require further well-designed clinical studies to confirm its safety, pharmacokinetics and efficacy in the treatment of human liver fibrosis. Major Findings: There is evidence of available experiments that Moringa oleifera suppresses hepatic fibrosis by lowering the oxidative stress and inflammatory cytokines, including TNF- α and IL-1β. Its bioactive compounds inhibit profibrotic signals such as TGF-β/Smad and p38-MAPK signalling and inhibit the activation of hepatic stellate cells and the deposition of collagen.
Zitieren
APA
., M., Negi, P., Singh, D., ., A., Kumari, S., & Ali, S. (2026). Anti-fibrotic Potential of Moringa oleifera in Hepatic Fibrosis: Molecular Mechanisms and Pharmacological Evidence. Journal of Natural Remedies, 1141-1158. https://doi.org/10.18311/jnr/2026/54532
Vancouver
. M, Negi P, Singh D, . A, Kumari S, Ali S. Anti-fibrotic Potential of Moringa oleifera in Hepatic Fibrosis: Molecular Mechanisms and Pharmacological Evidence. Journal of Natural Remedies. 2026:1141-1158. doi:10.18311/jnr/2026/54532
BibTeX
@article{2026,
author = {., Madhurani and Negi, Pooja and Singh, Digvijay and ., Alfisha and Kumari, Sweta and Ali, Shoyab},
title = {Anti-fibrotic Potential of Moringa oleifera in Hepatic Fibrosis: Molecular Mechanisms and Pharmacological Evidence},
journal = {Journal of Natural Remedies},
year = {2026},
pages = {1141--1158},
doi = {10.18311/jnr/2026/54532}
}
EUVIMED